MedTrace Logo

Concussion Testing: A Novel Non-invasive Concussion Detection Device

NCT02370914 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2022-08-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to establish and evaluate a distinctive signal for concussion.

Conditions

  • Concussion

Interventions

DEVICE

Nautilus NeuroWaveTM System

Recording of subjects with Nautilus NeuroWave diagnostic device

BEHAVIORAL

SCAT

A Neurocognitive evaluation of the patients to assess for concussion.

Sponsors & Collaborators

  • Jan Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Paul S Auerbach · Stanford University

Eligibility

Min Age
14 Years
Max Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02370914 on ClinicalTrials.gov